Alta Charo was a member of an Institute of Medicine committee that just released "Oversight and Review of Clinical Gene Transfer Protocols," a report outlining recommendations for improvements in oversight of gene therapy research, focusing on the balance between safety and innovation. The report also suggests consideration of oversight mechanisms across a host of other emerging technologies.

Submitted by Law School News on December 9, 2013

This article appears in the categories: Activities & Scholarship